Bank of America’s Procept Biorobotics PRCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-40,000
Closed -$1.41M 7904
2023
Q2
$1.41M Buy
+40,000
New +$1.32M ﹤0.01% 4513

Other funds holding PRCT

Bank of America's PRCT Position: Q1 2026 in Review

Bank of America increased its Procept Biorobotics (PRCT) stake by 46% in Q1 2026, buying an estimated $5.62M and bringing the position to 630,689 shares worth $15.8M. The position accounts for ﹤0.01% of the portfolio, ranked #2586.

Bank of America first reported a position in PRCT in Q3 2021 and has held it in 19 quarters since. The position peaked at $50.2M in Q4 2024. 256 funds tracked by Wall St. Rank hold PRCT as of Q1 2026.

  • Bank of America held 630,689 shares of Procept Biorobotics worth $15.8M as of Q1 2026.
  • Bank of America bought 199,484 Procept Biorobotics shares in Q1 2026, an estimated $5.62M.
  • Procept Biorobotics made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #2586 holding.
  • Bank of America first reported a position in Procept Biorobotics in Q3 2021 and has held it in 19 quarters since.
  • Bank of America's Procept Biorobotics position peaked at $50.2M in Q4 2024.
  • 256 funds tracked by Wall St. Rank held Procept Biorobotics as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.